# FDA Inspection 572502 - Biomat USA, Inc. - March 27, 2009

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cb244d3e-a82b-4b21-8d3f-10dab38b4401
Source feed: FDA_Inspections

> FDA Inspection 572502 for Biomat USA, Inc. on March 27, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 572502
- Company Name: Biomat USA, Inc.
- Inspection Date: 2009-03-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1108083 - 2019-10-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b702d93f-eaae-4b42-880d-01341fa0608e)
- [FDA Inspection 1028805 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/afd97781-508e-4568-899c-71511f40f4d2)
- [FDA Inspection 771978 - 2012-03-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cad96c9f-c57e-4366-a8f8-6524a81a89d7)

Company: https://www.keypedia.com/companies/biomat-usa-inc/2f79d685-1f13-4bed-8c37-f7b014075e76

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d